Thorax - McMaster Experts

publication venue for

P131 Patients with severe eosinophilic asthma achieved remission over 2 years with benralizumab: integrated analysis of the >1000-patient, multinational, real-world XALOC-1 study 2023
Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis 2019
P125 Balance impairment and clinical associations in individuals with COPD: a systematic review with meta-analysis 2018
P5 Prevalence of refractory chronic cough in a tertiary cough clinic 2018
S21 Cough rhythms in asthma 2018
M29 Fvc decline over 1 year predicts mortality but not subsequent fvc decline in patients with ipf 2017
M33 Long-term efficacy of nintedanib is maintained in patients with idiopathic pulmonary fibrosis (ipf) irrespective of dose: subgroup analysis of inpulsis-on 2017
M34 Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the tomorrow and inpulsis trials 2017
P106 The use of gabapentin and pregabalin for the management of chronic cough in a tertiary cough clinic 2017
P220 Profiling of occupations and exposures of patients diagnosed with occupational respiratory diseases at a uk regional referral unit 2017
S35 Randomised control trial quantifying the efficacy of low dose morphine in a responder group of patients with refractory chronic cough 2017
P134 Methacholine challenge to demonstrate therapeutic equivalence of terbutaline via different turbuhaler devices in patients with mild to moderate asthma: appraisal of a phase iii, four-way crossover design 2016
S98 Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatment 2016
P238 A randomised, double-blind (sponsor-unblind), placebo controlled, cross-over study to investigate the efficacy, effect on cough reflex sensitivity, safety, tolerability and pharmacokinetics of inhaled GSK2339345 in patients with chronic idiopathic cough using an aqueous droplet inhaler: Abstract P238 Table 1 2015
S108 Effect of baseline FVC on decline in lung function with nintedanib in patients with IPF: results from the INPULSIS® trials 2015
S91 A randomised, double-blind, placebo-controlled crossover study to assess the efficacy of a single dose of 100 mg of VRP700 by inhalation in reducing the frequency and severity of cough in adult patients with Idiopathic Pulmonary Fibrosis 2015
P10 The Effect Of Naltrexone, An Opioid Receptor Antagonist, On Capsaicin Evoked Cough, In Healthy Male Subjects 2014
P12 The Usefulness Of Heartburn As A Marker Of The Success Of Acid Suppression Therapy In Chronic Cough 2014
P252 Gold Category And Optimal Management : A Canadian Perspective 2014
P7 Neuronal Dysfunction In Asthma; Insights From The Study Of The Cough Reflex 2014
S125 A Comparison Between Weight Supported And Unsupported Exercise On Energy Expenditure And Cardiorespiratory Response During Exercise In Obese Adults With Treated Obstructive Sleep Apnoea 2014
S2 Development Of A Job Exposure Matrix For Soc 2000 Listings To Identify Occupational Causes Of Copd 2014
P219 Evaluating medical thoracoscopy services at a District General Hospital over the past 13 years 2013
P240 Assessing the Accuracy and Confidence of Chest X-Ray Reporting by Medical Doctors 2012
S69 Transcriptional Mechanisms Regulating Expression of the Avb6 Integrin in IPF 2012
S64 Understanding better the pathophysiology of aspiration pneumonia 2011
S125 Ly6Chi circulating monocytes direct alternatively activated, pro-fibrotic, lung macrophage regulation of pulmonary fibrosis 2010
CAN WE IMPROVE ADJUVANT CHEMOTHERAPY UPTAKE IN THE MANAGEMENT OF RESECTED LUNG CANCER? AN AUDIT OF PRACTICE ACROSS THE MID TRENT LUNG CANCER NETWORK 2009
COPD AND CHRONIC BRONCHITIS RISK OF SOLID FUEL SMOKE: A SYSTEMATIC REVIEW AND META-ANALYSIS 2009
AN AUDIT TO ASSESS THE ACCURACY OF POSITRON EMISSION TOMOGRAPHY SCANNING IN LUNG CANCER 2008
Audit of lung cancer waiting times at a district general hospital 2007
Intercostal drain insertion: A survey of general medical registrars in the mid trent region 2007
Smoking cessation advice for hospital inpatients: Room for improvement 2007
Baseline survey of practice in diagnosis and staging of carcinoma of the bronchus 2004
Effect of inhaled steroid withdrawal on exhaled nitric oxide in COPD: Preliminary data 2003
Her2 gene amplification and protein expression in non-small cell lung cancer 2000
Expression and prognostic influence of MMP-2, MMP-9 and TIMP-2 in non-small cell lung cancer 1999
Increased Chalkley microvessel counts are related to platelet count and convey poor prognosis in malignant mesothelioma 1999
Increased platelet and microvessel counts confer poor prognosis in operable non-small cell lung cancer 1999
MMP-9 and the epidermal growth factor signal pathway in non-small cell lung cancer 1999
CIMETIDINE PREVENTS HISTAMINE TACHYPHYLAXIS IN ASTHMATIC SUBJECTS 1987
IS ASTHMA BECOMING MORE SEVERE 1987
HUMAN INVITRO BRONCHIAL SMOOTH-MUSCLE RESPONSES TO LEUKOTRIENE D-4 IN RELATION TO THE QUANTITY OF MUSCLE 1986
AIRWAYS RESPONSIVENESS TO METHACHOLINE DURING THE NATURAL MENSTRUAL-CYCLE - EFFECT OF ORAL-CONTRACEPTIVES 1985
DOES THROMBOXAN-A2 MEDIATE THE INDIRECT CONTRACTILE EFFECT OF LEUCOTRIENE-D4 IN GUINEA-PIG LUNG PARENCHYMA 1985
EFFECT OF VERAPAMIL ON LEUCOTRIENE-D4 INDUCED BRONCHOCONSTRICTION IN ASTHMATIC-PATIENTS 1985
EFFECTS OF LEUCOTRIENE-D4 AND OTHER AGONISTS ON CA-45 EFFLUX FROM AIRWAY SMOOTH-MUSCLE 1985
RELATIVE POTENCY OF INHALED LEUKOTRIENES-C-4 AND LEUKOTRIENE-D-4 COMPARED WITH METHACHOLINE IN ASTHMATICS AND NORMALS 1985
VERAPAMIL INHIBITS LEUKOTRIENE D-INDUCED BRONCHOCONSTRICTION IN NORMAL SUBJECTS 1985
A MECHANISM FOR AIRWAY HYPERRESPONSIVENESS 1984
EFFECT OF PASSIVE SENSITIZATION OF HUMAN BRONCHIAL SMOOTH-MUSCLE ON INVITRO SENSITIVITY TO HISTAMINE 1984
THE RELATIONSHIP BETWEEN NEUTROPHILS AND HYPERRESPONSIVE AIRWAYS 1984
RELATIONSHIP BETWEEN INVIVO AIRWAY RESPONSIVENESS AND INVITRO SMOOTH-MUSCLE SENSITIVITY TO METHACHOLINE IN MAN 1983
INFLUENZA AND PARAINFLUENZA VIRUS TITERS IN BIRD FANCIERS WITH ACUTE ALLERGIC ALVEOLITIS 1976
CD206⁺macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis. 79:1124-1135. 2024
Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus. 78:1248-1253. 2023
Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis. 78:957-965. 2023
Longitudinal follow-up of postacute COVID-19 syndrome: DL_CO, quality-of-life and MRI pulmonary gas-exchange abnormalities. 78:418-421. 2023
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis. 77:1243-1250. 2022
Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial. 77:805-811. 2022
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study. 77:589-595. 2022
Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytes. 76:895-906. 2021
Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. 76:37-43. 2021
Sputum microbiota in adults with CF associates with response to inhaled tobramycin. 75:1058-1064. 2020
Balance impairment in individuals with COPD: a systematic review with meta-analysis. 75:539-546. 2020
Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab. 74:1087-1088. 2019
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis. 74:947-957. 2019
Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis. 73:1016-1025. 2018
Ventilation inhomogeneity in infants with recurrent wheezing. 73:936-941. 2018
Two pathways, one patient; UK asthma guidelines. 73:797-798. 2018
Lower respiratory infections in early life are linked to later asthma. 73:105-106. 2018
Pseudomonas aeruginosaLasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway. 73:49-61. 2018
The interaction between bronchoconstriction and cough in asthma. 72:1144-1146. 2017
Role of interleukin 33 in chronic rhinosinusitis. 72:591-593. 2017
MRI ventilation abnormalities predict quality-of-life and lung function changes in mild-to-moderate COPD: longitudinal TINCan study. 72:475-477. 2017
Long-term clinical outcomes of ‘Prairie Epidemic Strain’Pseudomonas aeruginosainfection in adults with cystic fibrosis. 72:333-339. 2017
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume. 72:340-346. 2017
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis. 72:148-153. 2017
Off-label use of inhaled tobramycin in Ontario, Canada. 71:862-864. 2016
Study the past to divine the future. Confucius' wisdom doesn't work for idiopathic pulmonary fibrosis. 71:399-400. 2016
Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals: a controlled human exposure study. 71:35-44. 2016
Interstitial lung disease: time to rethink the snapshot diagnosis?. 71:5-7. 2016
The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma: Table 1. 70:998-1000. 2015
Increased risk of mycobacterial infections associated with anti-rheumatic medications. 70:677-682. 2015
Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin. 70:636-646. 2015
Correction. 70:201-201. 2015
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. 69:312-319. 2014
Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?. 69:254-260. 2014
What are ventilation defects in asthma?. 69:63-71. 2014
On the role of abnormal DL_COin ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. 68:752-759. 2013
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β₂agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial. 68:513-520. 2013
Patients’ with obstructive sleep apnoea syndrome (OSAS) preferences and demand for treatment: a discrete choice experiment. 68:487-488. 2013
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. 68:142-148. 2013
The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility?. 68:195-198. 2013
Cigarette smoke and platelet-activating factor receptor dependent adhesion ofStreptococcus pneumoniaeto lower airway cells. 67:908-913. 2012
Physiotherapy interventions in the BTS guidelines on the management of asthma (2011): a need for change?: Table 1. 67:749-750. 2012
Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language?. 67:618-624. 2012
A role for sensory nerves in the late asthmatic response. 67:19-25. 2012
In memoriam: Frederick E Hargreave (1938-2011). 66:1101-1102. 2011
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. 66:680-685. 2011
Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. 65:486-491. 2010
Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. 65:379-383. 2010
Interval versus continuous training in individuals with chronic obstructive pulmonary disease- a systematic review. 65:157-164. 2010
Prospective randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. 65:93-94. 2010
Systemic inflammation and lung function in young adults. 62:1064-1068. 2007
Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects. 62:750-757. 2007
Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. 61:975-979. 2006
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. 61:969-974. 2006
Asthma exacerbations {middle dot} 1: Epidemiology. 61:722-728. 2006
How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. 60:367-375. 2005
B cell non-Hodgkin's lymphoma of the trachea mimicking COPD. 59:1100-1100. 2004
Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. 59:550-556. 2004
Relationship between socioeconomic status and asthma: a longitudinal cohort study. 59:376-380. 2004
Is there an association between impaired pulmonary function and mortality in never smokers?. 59:81. 2004
Influence of lung volume reduction surgery (LVRS) on health related quality of life in patients with chronic obstructive pulmonary disease. 58:405-410. 2003
Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). 58:23-29. 2003
Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). 56:954-959. 2001
A biological staging model for operable non-small cell lung cancer. 56:561-566. 2001
Cost-effectiveness benefits with formoterol turbuhaler twice daily versus salmeterol twice daily and as needed salbutamol. 55. 2000
Treatment of mild persistent asthma with low doses of inhaled budesonide alone or in combination with formoterol.. 55:A4-A4. 2000
Haemopoietic mechanisms in nasal polyposis and asthma. 55:24S-25. 2000
Induced sputum examination: diagnosis of pulmonary involvement in Fabry's disease. 55:720-721. 2000
Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients. 55:471-477. 2000
Relationship between fetal growth and the development of asthma and atopy in childhood. 54:905-910. 1999
Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: a meta-analysis. 54:884-893. 1999
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. 54:169-179. 1999
Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. 53:963-968. 1998
Measurement of airway hyperresponsiveness: new considerations. 53:419-424. 1998
Markers of inflammation in induced sputum in acute bronchitis caused by Chlamydia pneumoniae.. 52:929-931. 1997
Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators. 52:535-539. 1997
Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005. 52:348-354. 1997
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.. 51:1010-1016. 1996
Exacerbations of asthma without sputum eosinophilia.. 50:1057-1061. 1995
Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.. 50:834-837. 1995
Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.. 49:479-484. 1994
Bronchodilators and bronchial hyperresponsiveness.. 49:190-191. 1994
Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer.. 49:14-19. 1994
CYTOKINES .4. CYTOKINES AND PULMONARY FIBROSIS. 48:931-935. 1993
Cytokines and pulmonary fibrosis.. 48:931-935. 1993
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.. 48:871-871. 1993
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.. 48:776-776. 1993
Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.. 48:594-598. 1993
Miliary pulmonary cryptococcosis in a patient with the acquired immunodeficiency syndrome.. 48:402-403. 1993
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.. 48:134-138. 1993
Controlled trial of respiratory muscle training in chronic airflow limitation.. 48:96-96. 1993
Controlled trial of respiratory muscle training in chronic airflow limitation.. 47:598-602. 1992
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.. 47:76-83. 1992
Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation.. 47:70-75. 1992
Use of induced sputum cell counts to investigate airway inflammation in asthma.. 47:25-29. 1992
Reduced selenium in asthmatic subjects in New Zealand.. 45:95-99. 1990
Cellular characteristics of sputum from patients with asthma and chronic bronchitis.. 44:693-699. 1989
Effect of histamine on proliferation of normal human adult lung fibroblasts.. 43:552-558. 1988
Solitary fibrous tumour of the pleura: an ultrastructural and immunohistochemical study.. 42:976-979. 1987
A measure of quality of life for clinical trials in chronic lung disease.. 42:773-778. 1987
Use of anti-asthma drugs in New Zealand.. 42:670-675. 1987
Effect of verapamil and sodium cromoglycate on leukotriene D4 induced bronchoconstriction in patients with asthma.. 41:753-758. 1986
Interpretation of the variability of peak flow rates in chronic bronchitis.. 41:771-776. 1986
Reply. 41:705-706. 1986
Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children.. 41:283-289. 1986
In vitro and in vivo effect of verapamil on human airway responsiveness to leukotriene D4.. 41:12-16. 1986
Differences in responsiveness to hyperventilation and methacholine in asthma and chronic bronchitis.. 40:422-426. 1985
Airway responsiveness to histamine in man: effect of atropine on in vivo and in vitro comparison.. 40:261-267. 1985
Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness.. 39:912-918. 1984
Comparison of in vivo airway responsiveness and in vitro smooth muscle sensitivity to methacholine in man.. 39:837-843. 1984
Effect of encouragement on walking test performance.. 39:818-822. 1984
Histamine inhalation tests: inhalation of aerosol via a facemask versus a valve box with mouthpiece.. 39:556-557. 1984
Pattern of breathing during exercise in patients with interstitial lung disease.. 38:778-784. 1983
Usefulness of transbronchial biopsy in immunosuppressed patients with pulmonary infiltrates.. 38:146-150. 1983
Inhibition of the bronchial response to respiratory heat exchange by increasing doses of terbutaline sulphate.. 37:913-917. 1982
Not enough exercise?. 37:793-794. 1982
Long-term stability of bronchial responsiveness to histamine.. 37:288-291. 1982
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma.. 36:575-579. 1981
Reproducibility and comparison of responses to inhaled histamine and methacholine.. 33:705-710. 1978
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.. 32:194-197. 1977
Relation between abnormalities in the chest radiograph and changes in pulmonary function in chronic bronchitis and emphysema. 28:15-23. 1973
Pulmonary alveolar microlithiasis. 26:704-711. 1971
Effort tolerance and exercise responses in men with chronic diffuse airways obstruction.. 24:506-506. 1969
Serial studies of 100 patients with chronic airway obstruction in London and Chicago. 22:327-335. 1967

has subject area

1103 Clinical Sciences (FoR)
Respiratory System (Science Metrix)

Thorax Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)